PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2017 | 77 | Suppl.1 |
Tytuł artykułu

NGS as a diagnostic tool for unexplained limb-girdle muscles weakness: Results of European MYO-SEQ project in 75 Polish patients

Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
INTRODUCTION: Hereditary muscle disorders are a genetically heterogeneous group of rare diseases with overlapping phenotypes causing difficulties in establishing a diagnosis. Genetic testing isthe only reliable tool to confirm a prompt diagnosis.Genetically confirmed diagnosisisrequired forthe future targeted therapies and the genetic counselling. Department of Neurology, Warsaw Medical University, participated in a European multicenter project MYO‑SEQ led by Institute of Genetic Medicine, Newcastle University. AIM(S): The main aim of the project was to establish accurate diagnoses in patients with unexplained limb-girdle muscle weakness by applying New Generation Sequencing(NGS). MATERIAL Patients included in the study were at least 10 years old, presented with unexplained limb-girdle or respiratory muscle weakness and/or elevated serum CK activity. Based on these criteria we identified 75 patients treated at our Department of Neurology. METHOD(S): With the patients’ consent, their encoded DNA samples and anonymous clinical data were sent to the MYO‑SEQ coordinating center for a whole exome sequencing using NGS. A detailed analysis of potential mutations was restricted to 169 gene associated with neuromuscular disorders. When the molecular result were obtained, a detail clinical-genetic analysis was done. RESULTS: In total of 75 tested samples, 50 (66,7%) showed specific mutations responsible for the patients’ symptoms, including 45 (60,0%) with mutation in a single gene. In 5 samples (6,7%), mutations in more than one gene were found. In two patients the treatable diseases were identified: Pompe disease and congenital myasthenic syndrome. In 25 (33,3%) samples, no strong candidate gene was identified. CONCLUSIONS: NGS offers an accurate and reliable methodology to establish a diagnosis in rare inherited muscle diseases.When the new molecular therapies become available, NGS test should be included in a standard diagnostic procedure of myopathies.
Słowa kluczowe
Wydawca
-
Rocznik
Tom
77
Numer
Opis fizyczny
p.76
Twórcy
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
autor
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
autor
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
autor
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
autor
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
autor
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
autor
  • Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA
  • Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, USA
autor
  • Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA
  • Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, USA
  • Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA
  • Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, USA
autor
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
autor
  • Students’ Scientific Group by the Department of Neurology, Medical University of Warsaw, Warsaw, Poland
  • Students' Scientific Group by the Department of Neurology, Medical University of Warsaw, Warsaw, Poland
autor
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland
Bibliografia
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-c7f18f7a-31c2-40ec-82ea-e92b1105b962
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.